2022---dr--martens-sieht-gewinnausf-lle-und-erh-ht-die-dividende-um-28-----magazin--gesundheits--und-sportnachrichten -

: The 28% dividend increase was a deliberate signal of management's "confidence in the future" despite the profit headwinds. This payout represented roughly 35% of earnings.

In 2022, Dr. Martens reported a mixed financial performance, characterized by alongside profitability pressures that led to a significant dividend increase . While the company achieved an 18% growth in underlying revenue during the first half of its financial year, it simultaneously faced "profit shortfalls" in the form of lower margins due to ongoing investments and a weakening economic environment. Key Financial Highlights (FY23 H1) : The 28% dividend increase was a deliberate

: Lower EBITDA margins were attributed to planned investments in new stores , marketing, and technology, as well as rising cost inflation which the company aimed to offset with price increases in 2023. Martens reported a mixed financial performance